Cooper Operating Income 2010-2024 | COO

Cooper annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Cooper operating income for the quarter ending April 30, 2024 was $0.162B, a 67.91% increase year-over-year.
  • Cooper operating income for the twelve months ending April 30, 2024 was $0.602B, a 22.9% increase year-over-year.
  • Cooper annual operating income for 2023 was $0.533B, a 5.02% increase from 2022.
  • Cooper annual operating income for 2022 was $0.508B, a 0.36% increase from 2021.
  • Cooper annual operating income for 2021 was $0.506B, a 62.22% increase from 2020.
Cooper Annual Operating Income
(Millions of US $)
2023 $533
2022 $508
2021 $506
2020 $312
2019 $547
2018 $403
2017 $429
2016 $324
2015 $237
2014 $306
2013 $306
2012 $283
2011 $228
2010 $190
2009 $150
Cooper Quarterly Operating Income
(Millions of US $)
2024-04-30 $162
2024-01-31 $153
2023-10-31 $136
2023-07-31 $152
2023-04-30 $96
2023-01-31 $150
2022-10-31 $104
2022-07-31 $141
2022-04-30 $133
2022-01-31 $131
2021-10-31 $129
2021-07-31 $101
2021-04-30 $143
2021-01-31 $133
2020-10-31 $100
2020-07-31 $72
2020-04-30 $29
2020-01-31 $111
2019-10-31 $147
2019-07-31 $142
2019-04-30 $147
2019-01-31 $111
2018-10-31 $123
2018-07-31 $116
2018-04-30 $75
2018-01-31 $90
2017-10-31 $109
2017-07-31 $113
2017-04-30 $117
2017-01-31 $91
2016-10-31 $74
2016-07-31 $103
2016-04-30 $90
2016-01-31 $57
2015-10-31 $42
2015-07-31 $50
2015-04-30 $71
2015-01-31 $73
2014-10-31 $39
2014-07-31 $97
2014-04-30 $89
2014-01-31 $82
2013-10-31 $62
2013-07-31 $94
2013-04-30 $81
2013-01-31 $69
2012-10-31 $79
2012-07-31 $77
2012-04-30 $65
2012-01-31 $62
2011-10-31 $67
2011-07-31 $52
2011-04-30 $60
2011-01-31 $49
2010-10-31 $63
2010-07-31 $51
2010-04-30 $39
2010-01-31 $37
2009-10-31 $42
2009-07-31 $34
2009-04-30 $41
2009-01-31 $33
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.251B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00